» Articles » PMID: 35145963

Systems Biology Modeling of the Complement System Under Immune Susceptible Pathogens

Overview
Journal Front Phys
Date 2022 Feb 11
PMID 35145963
Authors
Affiliations
Soon will be listed here.
Abstract

The complement system is assembled from a network of proteins that function to bring about the first line of defense of the body against invading pathogens. However, complement deficiencies or invasive pathogens can hijack complement to subsequently increase susceptibility of the body to infections. Moreover, invasive pathogens are increasingly becoming resistant to the currently available therapies. Hence, it is important to gain insights into the highly dynamic interaction between complement and invading microbes in the frontlines of immunity. Here, we developed a mathematical model of the complement system composed of 670 ordinary differential equations with 328 kinetic parameters, which describes all three complement pathways (alternative, classical, and lectin) and includes description of mannose-binding lectin, collectins, ficolins, factor H-related proteins, immunoglobulin M, and pentraxins. Additionally, we incorporate two pathogens: (type 1) complement susceptible pathogen and (type 2) located in either nasopharynx or bloodstream. In both cases, we generate time profiles of the pathogen surface occupied by complement components and the membrane attack complex (MAC). Our model shows both pathogen types in bloodstream are saturated by complement proteins, whereas MACs occupy <<1.0% of the pathogen surface. Conversely, the MAC production in nasopharynx occupies about 1.5-10% of the total surface, thus making nasal MAC levels at least about eight orders of magnitude higher. Altogether, we predict complement-imbalance, favoring overactivation, is associated with nasopharynx homeostasis. Conversely, orientating toward complement-balance may cause disruption to the nasopharynx homeostasis. Thus, for sporadic meningococcal disease, our model predicts rising nasal levels of complement regulators as early infection biomarkers.

Citing Articles

Unravelling the impact of SARS-CoV-2 on hemostatic and complement systems: a systems immunology perspective.

Murad D, Paracha R, Nisar M Front Immunol. 2025; 15:1457324.

PMID: 39885991 PMC: 11781117. DOI: 10.3389/fimmu.2024.1457324.


Modelling and analysis of the complement system signalling pathways: roles of C3, C5a and pro-inflammatory cytokines in SARS-CoV-2 infection.

Murad D, Paracha R, Saeed M, Ahmad J, Mushtaq A, Humayun M PeerJ. 2023; 11:e15794.

PMID: 37744234 PMC: 10517668. DOI: 10.7717/peerj.15794.


Complement system in Anti-CD20 mAb therapy for cancer: A mini-review.

Gao Y Int J Immunopathol Pharmacol. 2023; 37:3946320231181464.

PMID: 37357623 PMC: 10331094. DOI: 10.1177/03946320231181464.


The Factor H protein family: The switchers of the complement alternative pathway.

Lucientes-Continente L, Marquez-Tirado B, Goicoechea de Jorge E Immunol Rev. 2022; 313(1):25-45.

PMID: 36382387 PMC: 10099856. DOI: 10.1111/imr.13166.


Mathematical Modeling of Complement Pathway Dynamics for Target Validation and Selection of Drug Modalities for Complement Therapies.

Bansal L, Nichols E, Howsmon D, Neisen J, Bessant C, Cunningham F Front Pharmacol. 2022; 13:855743.

PMID: 35517827 PMC: 9061988. DOI: 10.3389/fphar.2022.855743.

References
1.
Wright V, Hibberd M, Levin M . Genetic polymorphisms in host response to meningococcal infection: the role of susceptibility and severity genes. Vaccine. 2009; 27 Suppl 2:B90-102. DOI: 10.1016/j.vaccine.2009.05.002. View

2.
Ugurlar D, Howes S, de Kreuk B, Koning R, de Jong R, Beurskens F . Structures of C1-IgG1 provide insights into how danger pattern recognition activates complement. Science. 2018; 359(6377):794-797. DOI: 10.1126/science.aao4988. View

3.
Gorguner M, Akgun M . Acute inhalation injury. Eurasian J Med. 2015; 42(1):28-35. PMC: 4261306. DOI: 10.5152/eajm.2010.09. View

4.
Zewde N, Morikis D . A computational model for the evaluation of complement system regulation under homeostasis, disease, and drug intervention. PLoS One. 2018; 13(6):e0198644. PMC: 5991421. DOI: 10.1371/journal.pone.0198644. View

5.
Skattum L, van Deuren M, van der Poll T, Truedsson L . Complement deficiency states and associated infections. Mol Immunol. 2011; 48(14):1643-55. DOI: 10.1016/j.molimm.2011.05.001. View